Figure 1.

Efficacy outcomes. (A) Best overall response achieved. (B) Progression-free survival from date of CAR T-cell infusion to time of progression, relapse, or death. (C) Progression-free survival stratified by best overall response achieved. (D) Overall survival from date of CAR T-cell infusion to date of death. (E) Overall survival stratified by best overall response achieved. (B–E) Dashed lines represent median time. Abbreviations: CI, confidence interval; CR, complete response; HR, hazard ratio; NR, not reached; OS, overall survival; PD, progressive disease; PFS, progression-free survival; PR, partial response; SD, stable disease.